A phase I, multicenter study of S-1 plus oral leucovorin in patients with metastatic colorectal cancer
Latest Information Update: 10 Jul 2017
Price :
$35 *
At a glance
- Drugs Folinic acid (Primary) ; Gimeracil/oteracil/tegafur (Primary)
- Indications Colorectal cancer
- Focus Adverse reactions
- Sponsors Taiho Pharmaceutical
- 10 Jul 2017 New trial record